Research

Hormonal

Preoperative use of GLP-1 receptor agonists does not improve long-term weight loss, diabetes remission, or surgical safety outcomes in patients undergoing metabolic bariatric surgery compared to those who do not use GLP-1s.

If you are considering bariatric surgery, using GLP-1 drugs (like Ozempic or Wegovy) beforehand does not appear to make your surgery more successful or your weight loss better in the long run. In fact, it may just delay getting the more effective surgical treatment. If you are experiencing side effects from these drugs or they aren't working well enough, switching to surgery is a valid and effective path, but don't expect the drugs to give you a 'head start' on your results.

GoodRefutesMEDIUM confidence
Among patients who proceeded to surgery after GLP-1 therapy, prior GLP-1 use was not associated with different surgical outcomes.
Adisa Poljo et al. · Obesity Surgery · 2025

Why this rating

Retrospective analysis with propensity score matching, but limited by single-center design, small sample size (n=215), and low statistical power (29%) to detect small differences.

Source

Surgical Outcomes in Patients with Preoperative GLP-1 Therapy: A Retrospective Analysis

Adisa Poljo et al. · Obesity Surgery · 2025

DOI 10.1007/s11695-025-08136-5

cohort · n=215Cited 9×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →